# pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD

> **NCT05957341** · NA · UNKNOWN · sponsor: **Changping Laboratory** · enrollment: 50 (estimated)

## Conditions studied

- Moderate Depression
- Major Depressive Disorder
- Severe Depression

## Interventions

- **DEVICE:** active rTMS: 20min inter-session interval
- **DEVICE:** active rTMS: 50min inter-session interval
- **DEVICE:** sham rTMS: 20min inter-session interval
- **DEVICE:** sham rTMS: 50min inter-session interval

## Key facts

- **NCT ID:** NCT05957341
- **Lead sponsor:** Changping Laboratory
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-30
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2023-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05957341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05957341, "pBFS Guided 20min Inter-session Interval rTMS Treatment for MDD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05957341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
